Basics Absci Corporation Common Stock IPO Date: July 22, 2021 Sector: Healthcare Industry: Biotech Market Cap: $547.35M Activated in VL: True Average Daily Range Avg Daily Range: $0.22 | 4.40% Avg Daily Range (30 D): $0.13 | 3.88% Avg Daily Range (90 D): $0.13 | 3.92% Institutional Daily Volume Avg Daily Volume: 1.59M Avg Daily Volume (30 D): 4.24M Avg Daily Volume (90 D): 4.77M Trade Size Avg Trade Size (Sh.): 175 Avg Trade Size (Sh.) (30 D): 232 Avg Trade Size (Sh.) (90 D): 240 Institutional Trades Total Inst.Trades: 247 Avg Inst. Trade: $1.68M Avg Inst. Trade (30 D): $.75M Avg Inst. Trade (90 D): $.92M Avg Inst. Trade Volume: .37M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $1.79M Avg Closing Trade (30 D): $.77M Avg Closing Trade (90 D): $.98M Avg Closing Volume: 408.2K     News Oct 29, 2025 @ 8:05 PM Absci to Report Business Updates and Third Quarter... Source: Globe Newswire Oct 27, 2025 @ 12:00 PM Absci to Participate in Upcoming Investor Conferen... Source: Absci Corporation Oct 14, 2025 @ 3:41 PM Absci Stock Offers High-Risk AI Biotech Exposure W... Source: Nathan Reiff Oct 9, 2025 @ 3:00 PM Computer-Aided Drug Design (CADD) Market Competiti... Source: Towards Healthcare Sep 11, 2025 @ 4:10 PM Absci Boosts AI-Powered Drug Discovery With Oracle... Source: Vandana Singh Financials   TTM Q2 2025 Q1 2025 Basic EPS $-.2 $-.24 $-.21 Diluted EPS $-.2 $-.24 $-.21 Revenue $ .38M $ .59M $ 1.18M Gross Profit $ $ $ Net Income / Loss $ -28.71M $ -30.57M $ -26.35M Operating Income / Loss $ -30.15M $ -31.39M $ -27.73M Cost of Revenue $ $ $ Net Cash Flow $ -28.42M $ -8.84M $ 5.91M PE Ratio